Increased need for right ventricular support in patients with chemotherapy-induced cardiomyopathy undergoing mechanical circulatory support: Outcomes from the intermacs registry (interagency registry for mechanically assisted circulatory support)

Journal of the American College of Cardiology

Volumn 63, Issue 3, 2014, Pages 240-248

  Oliveira, Guilherme H ^a   Dupont, Matthias ^b   Naftel, David ^c   Myers, Susan L ^c   Yuan, Ya ^c   Wilson Tang, W H ^a   Gonzalez Stawinski, Gonzalo ^d   Young, James B ^a   Taylor, David O ^a   Starling, Randall C ^a  

^a UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^b DEPARTMENT OF CARDIOLOGY   (Belgium)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^d BAYLOR UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

assist devices; chemotherapy induced cardiomyopathy; heart failure

Indexed keywords

ADULT; ARTICLE; ASSISTED CIRCULATION; BLEEDING; CARDIOMYOPATHY; CHEMOTHERAPY INDUCED CARDIOMYOPATHY; CONTROLLED STUDY; DRUG INDUCED DISEASE; FEMALE; HEART FAILURE; HIGH RISK PATIENT; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; IMPLANTATION; ISCHEMIC CARDIOMYOPATHY; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NONISCHEMIC CARDIOMYOPATHY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RIGHT VENTRICULAR ASSIST DEVICE; SURVIVAL RATE; TREATMENT OUTCOME; DISEASE PREDISPOSITION; END STAGE HEART FAILURE; MECHANICAL CIRCULATORY SUPPORT; OUTCOME ASSESSMENT; PROGNOSTIC ASSESSMENT; SEX RATIO; TREATMENT INDICATION;

ASSIST DEVICES; CCMP; CHEMOTHERAPY-INDUCED CARDIOMYOPATHY; HEART FAILURE; ICMP; ISCHEMIC CARDIOMYOPATHY; LEFT VENTRICULAR ASSIST DEVICE; LVAD; MCS; MECHANICAL CIRCULATORY SUPPORT; NICMP; NONISCHEMIC CARDIOMYOPATHY; RIGHT VENTRICULAR; RIGHT VENTRICULAR ASSIST DEVICE; RV; RVAD;

ANTINEOPLASTIC AGENTS; CARDIOMYOPATHIES; CAUSE OF DEATH; FEMALE; FOLLOW-UP STUDIES; HEART-ASSIST DEVICES; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; REGISTRIES; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME; UNITED STATES;

ANTHRACYCLINE DERIVATIVE;

EID: 84892702061     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2013.09.040     Document Type: Article

References (22)

1. J. Chen, J.B. Long, A. Hurria, C. Owusu, R.M. Steingart, and C.P. Gross Incidence of heart failure or cardiomyopathy after adjuvant trastuzumab therapy for breast cancer J Am Coll Cardiol 60 2012 2504 2512
2. E.H. Romond, J.H. Jeong, and P. Rastogi et al. Seven-year follow-up assessment of cardiac function in NSABP B-31, a randomized trial comparing doxorubicin and cyclophosphamide followed by paclitaxel (ACP) with ACP plus trastuzumab as adjuvant therapy for patients with node-positive, human epidermal growth factor receptor 2-positive breast cancer J Clin Oncol 30 2012 3792 3799
3. D.A. Mulrooney, M.W. Yeazel, and T. Kawashima et al. Cardiac outcomes in a cohort of adult survivors of childhood and adolescent cancer: retrospective analysis of the Childhood Cancer Survivor Study cohort BMJ 339 2009 b4606
4. G.M. Felker, R.E. Thompson, and J.M. Hare et al. Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy N Engl J Med 342 2000 1077 1084
5. G.H. Oliveira, B.W. Hardaway, A.Y. Kucheryavaya, J. Stehlik, L.B. Edwards, and D.O. Taylor Characteristics and survival of patients with chemotherapy-induced cardiomyopathy undergoing heart transplantation J Heart Lung Transplant 31 2012 805 810
6. M.R. Costanzo, A. Dipchand, R. Starling International Society of Heart and Lung Transplantation The International Society of Heart and Lung Transplantation Guidelines for the care of heart transplant recipients J Heart Lung Transplant 29 2010 914 956
7. J.K. Kirklin, D.C. Naftel, F.D. Pagani, R.L. Kormos, L. Stevenson, M. Miller, and J.B. Young Long-term mechanical circulatory support (destination therapy): on track to compete with heart transplantation? J Thorac Cardiovasc Surg 144 2012 584 603 discussion 597-8
8. M.S. Slaughter, J.G. Rogers, C.A. Milano HeartMate II Investigators Advanced heart failure treated with continuous-flow left ventricular assist device N Engl J Med 361 2009 2241 2251
9. M. Freilich, D. Stub, and D. Esmore et al. Recovery from anthracycline cardiomyopathy after long-term support with a continuous flow left ventricular assist device J Heart Lung Transplant 28 2009 101 103
10. S.A. Simsir, S.S. Lin, L.J. Blue, J.P. Gockerman, S.D. Russell, and C.A. Milano Left ventricular assist device as destination therapy in doxorubicin-induced cardiomyopathy Ann Thorac Surg 80 2005 717 719
11. J.K. Kirklin, D.C. Naftel, and L.W. Stevenson et al. INTERMACS database for durable devices for circulatory support: first annual report J Heart Lung Transplant 27 2008 1065 1072
12. K. Fukamachi, P.M. McCarthy, N.G. Smedira, R.L. Vargo, R.C. Starling, and J.B. Young Preoperative risk factors for right ventricular failure after implantable left ventricular assist device insertion Ann Thorac Surg 68 1999 2181 2184
13. J. Baumwol, P.S. Macdonald, and A.M. Keogh et al. Right heart failure and "failure to thrive" after left ventricular assist device: clinical predictors and outcomes J Heart Lung Transplant 30 2011 888 895
14. E.V. Potapov, A. Stepanenko, and M. Dandel et al. Tricuspid incompetence and geometry of the right ventricle as predictors of right ventricular function after implantation of a left ventricular assist device J Heart Lung Transplant 27 2008 1275 1281
15. A. Yilmaz, I. Kindermann, and M. Kindermann et al. Comparative evaluation of left and right ventricular endomyocardial biopsy: differences in complication rate and diagnostic performance Circulation 122 2010 900 909
16. J.C. Cleveland Jr., D.C. Naftel, and T.B. Reece et al. Survival after biventricular assist device implantation: an analysis of the Interagency Registry for Mechanically Assisted Circulatory Support database J Heart Lung Transplant 30 2011 862 869
17. N.C. Dang, V.K. Topkara, and M. Mercando et al. Right heart failure after left ventricular assist device implantation in patients with chronic congestive heart failure J Heart Lung Transplant 25 2006 1 6
18. J.R. Fitzpatrick 3rd, J.R. Frederick, and W. Hiesinger et al. Early planned institution of biventricular mechanical circulatory support results in improved outcomes compared with delayed conversion of a left ventricular assist device to a biventricular assist device J Thorac Cardiovasc Surg 137 2009 971 977
19. M.A. Friedman, M.J. Bozdech, M.E. Billingham, and A.K. Rider Doxorubicin cardiotoxicity. Serial endomyocardial biopsies and systolic time intervals JAMA 240 1978 1603 1606
20. M.E. Billingham Pharmacotoxic myocardial disease: an endomyocardial study Heart Vessels Suppl 1 1985 278 282
21. C.E. Freter, T.C. Lee, M.E. Billingham, L. Chak, and M.R. Bristow Doxorubicin cardiac toxicity manifesting seven years after treatment. Case report and review Am J Med 80 1986 483 485
22. P. Rojnuckarin, N. Uaprasert, B. Akkawat, R. Settapiboon, T. Nanakorn, and T. Intragumtornchai Protein C, protein S and von Willebrand factor levels correlate with bleeding symptoms: a population-based study Haemophilia 18 2012 457 462